Montreal-based medtech startup Reveal Life Science won the OVHcloud Startup Challenge at VivaTech in Paris by showcasing its AI technology that rapidly distinguishes cancerous and healthy tissues during surgery using molecular analysis.
- Reveal Life Science uses AI and Raman spectroscopy for intraoperative cancer detection.
- Data hosting is handled securely by Canadian company Qohash, ensuring data control.
- Reveal recently partnered with IRCAD for breast cancer surgery application and holds FDA Breakthrough Device status.
What happened
Reveal Life Science, a Canadian medical AI startup based in Montreal, claimed first place at the OVHcloud Startup Challenge held during VivaTech, one of Europe's largest technology conferences in Paris. Their technology employs Raman spectroscopy combined with artificial intelligence to analyze tissue samples within seconds, distinguishing healthy from cancerous tissues with high speed and accuracy during surgery.
The company boasts possession of the world’s largest molecular dataset used to train its AI platform. Reveal’s data management benefits from collaboration with Qohash, another Canadian startup specializing in secure data hosting, which ensures sensitive medical data remains under the control of its rightful owners.
Why it matters
Reveal Life Science’s technology addresses a critical challenge in oncology surgery: the complete removal of cancerous tumors without leaving residual malignant cells that could cause tumor regrowth. Their AI platform has been tested in over 700 surgeries with more than 20,000 real-time tissue measurements, currently achieving 93 to 97 percent accuracy on brain tumor detections.
The ability to differentiate tissues precisely during operations could significantly improve surgical outcomes, reduce repeat procedures, and enhance patient survival rates. This breakthrough also supports Canada’s growing reputation as a hub for AI innovation in healthcare, leveraging local expertise in both AI development and secure data infrastructure.
What to watch next
With federal initiatives such as Scale AI promoting Canadian AI startups internationally and government strategies aiming to form alliances around AI governance, Reveal’s success at VivaTech highlights increasing opportunities for Canadian healthtech companies to gain traction on the global stage. Tracking regulatory progress and international collaborations will be important in assessing Reveal’s commercial and clinical impact.